1 |
Ingulli E, Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience. Transplantation 1991;51:401-5.
DOI
ScienceOn
|
2 |
Sener A, Bella AJ, Nguan C, Luke PP, House AA. Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function. Clin Transplant 2009;23:96- 100.
DOI
ScienceOn
|
3 |
Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P, et al. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int 2007;20:102-5.
DOI
ScienceOn
|
4 |
Ahn YH, Jung E, Lee SE, Lee HK, Lee SH, Kang HG, et al. Peritoneal protein loss in nephrotic syndrome on peritoneal dialysis. J Korean Soc Pediatr Nephrol 2009;13:189-96.
DOI
|
5 |
Senggutuvan P, Cameron JS, Hartley RB, Rigden S, Chantler C, Haycock G, et al. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 1990;4:21-8.
DOI
ScienceOn
|
6 |
Vinai M, Waber P, Seikaly MG. Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review. Pediatr Transplant 2010;14:314-25.
DOI
ScienceOn
|
7 |
Choi HJ, Lee BH, Cho HY, Moon KC, Ha IS, Nagata M, et al. Familial focal segmental glomerulosclerosis associated with an ACTN4 mutation and paternal germline mosaicism. Am J Kidney Dis 2008;51:834-8.
DOI
ScienceOn
|
8 |
Cho HY, Lee JH, Choi HJ, Lee BH, Ha IS, Choi Y, et al. WT1 and NPHS2 mutations in Korean children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 2008;23:63-70.
|
9 |
Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 1990;4:303-7.
DOI
ScienceOn
|
10 |
Sharma M, Sharma R, McCarthy ET, Savin VJ. The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects. Exp Biol Med (Maywood) 2004;229:85-98.
DOI
|
11 |
Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008;14:931-8.
DOI
ScienceOn
|
12 |
Bensman A, Niaudet P. Non-immunologic mechanisms of calcineurin inhibitors explain its antiproteinuric effects in genetic glomerulopathies. Pediatr Nephrol 2010;25:1197-9.
DOI
ScienceOn
|
13 |
Fuchshuber A, Jean G, Gribouval O, Gubler MC, Broyer M, Beckmann JS, et al. Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet 1995;4:2155-8.
DOI
ScienceOn
|
14 |
Cheong HI, Han HW, Park HW, Ha IS, Han KS, Lee HS, et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000;15:78- 81.
|
15 |
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A. Efficacy and safety of tacrolimus versus cyclosporine in children with steroidresistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis 2009;53:760-9.
DOI
ScienceOn
|
16 |
Mekahli D, Liutkus A, Ranchin B, Yu A, Bessenay L, Girardin E, et al. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol 2009;24:1525-32.
DOI
ScienceOn
|
17 |
Lee HK, Han KH, Jung YH, Kang HG, Moon KC, Ha IS, et al. Variable renal phenotype in a family with an INF2 mutation. Pediatr Nephrol 2011;26:73-6.
DOI
ScienceOn
|
18 |
Lee BH, Ahn YH, Choi HJ, Kang HK, Kim SD, Cho BS, et al. Two Korean infants with genetically confirmed congenital nephrotic syndrome of finnish type. J Korean Med Sci 2009;24(Suppl 1):S210-4.
DOI
|
19 |
Benoit G, Machuca E, Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 2010;25:1621-32.
DOI
ScienceOn
|
20 |
McCarthy ET, Sharma M, Savin VJ. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2010;5:2115-21.
DOI
ScienceOn
|
21 |
Vecsei AK, Muller T, Schratzberger EC, Kircher K, Regele H, Arbeiter K, et al. Plasmapheresis-induced remission in otherwise therapy-resistant FSGS. Pediatr Nephrol 2001;16:898-900.
DOI
ScienceOn
|
22 |
Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M. Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 2005;20:1660-3.
DOI
ScienceOn
|
23 |
Prytuła A, Iijima K, Kamei K, Geary D, Gottlich E, Majeed A, et al. Rituximab in refractory nephrotic syndrome. Pediatr Nephrol 2010; 25:461-8.
DOI
ScienceOn
|
24 |
Lands LC. New therapies, new concerns: rituximab-associated lung injury. Pediatr Nephrol 2010;25:1001-3.
DOI
ScienceOn
|